{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-231310","form_type":"8-K","ticker":"ENTA","cik":"0001177648","company_name":"ENANTA PHARMACEUTICALS INC","filed_at":"2022-08-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:55.139783+00:00","generated_at":"2026-06-23T20:50:00.579436+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Enanta Pharmaceuticals enters ATM agreement with Jefferies for up to $100M common stock offering","bullets":["Open Market Sale Agreement with Jefferies LLC allows at-the-market sales of up to $100M in common stock.","Jefferies will receive a 3.0% commission on gross sales price per share sold under the agreement.","Shares sold on Nasdaq Global Select Market or other trading venues; company has no obligation to sell.","Offering terminates upon sale of all shares or termination of the agreement per its terms."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-231310","json":"https://secwatch.observer/filing/0001193125-22-231310.json","markdown":"https://secwatch.observer/filing/0001193125-22-231310.md","text":"https://secwatch.observer/filing/0001193125-22-231310.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1177648/000119312522231310/0001193125-22-231310-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1177648/000119312522231310/d376393d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T20:50:00.579436+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}